Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary phase I results for ILX-651 discussed at AACR meeting

April 15, 2002

Preclinical characterization of Ro-31-7453, a new cell cycle inhibitor

April 15, 2002

Potent inhibitors of angiogenesis derived from thrombospondin-1

April 15, 2002

Cephalon designs new inhibitors of VEGF-dependent angiogenesis with good oral antitumor activity

April 15, 2002

Prodrugs of betulinic acid or derivatives designed for the treatment of tumors, HIV

April 12, 2002

Phase Ib of TNFerade in solid tumors completes enrollment

April 12, 2002

TLK-286 enters phase II in breast cancer

April 12, 2002

Sloan-Kettering identifies novel antitumor macrocycles

April 12, 2002

Allos licenses N-Gene's chemoprotective agent BGP-15

April 12, 2002

Potent and selective MRP1 inhibitors considered promising clinical candidates

April 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...